Description
Since its foundation in 2001, Biotechnet has executed over 150 successful projects with industry and other research partners. Here are a few highlights from 2013-2015, financed by the Commission for Technology and Innovation (CTI).
2015
- Entwicklung eines immunresponsiven in vitro 3D in vitro Systems (DermaInf) zur Bestimmung der immunsuppressiven und kollagenstimulierenden Wirkung von kosmetischen Wirkstoffen.
- Skin Layer Detection
- Anti-Fibroblast Activation Protein immunotherapy.
- 3D Gewebemodelle – neue Perspektiven für die Medizin.
- Innovative Biokatalyse – Toolbox für eine nachhaltige biobasierte produktion.
- OilGuard – Oil in Water Monitoring
- Bioprinted kidney model for nephrotoxicity assessment
- Microfluidic two-tissue platform for combined drug efficacy and toxicity testing
2014
- F u. E Projekt : Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to antibodies
- R and D project : A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues
- PiFPaF - Pipettiersystem mit Flusssensor und Mikroelement zur passiven Flussregelung
- VALIPLATE - Calorimetric tool for validating the liquid volume dispensed by liquid handling instruments
- F u. E Projekt : New drugs for the treatment of diabetes based on an herbal medicinal product
- Automatisierte Extraktion von Trockenblutproben für das Neugeborenenscreening
2013
- F u. E Projekt : HIT to LEAD to Preclinical Candidate development of a Transcription Repressor Inhibitory Compound (TRIC) that increase antibiotic susceptibility of multidrug resistant staphylococci
- A robust CHO cell-based process platform for rapid manufacture of novel fully human bispecific monoclonal antibodies with importance for preclinical studies, immuno- and cancer therapies
- Prozessoptimierung für die Herstellung eines humanen monoklonalen Antikörpers mittels einer Hybridoma Zelllinie zur Therapie von MRS Infektionen
- Entwicklung einer magnetgelagerten single-use Zentrifugalpumpe für biopharmazeutische Applikationen
- Gepulstes nano Dosierventil mit integriertem Mass Flow Controller
- Entwicklung und Markteinführung eines Marker-freien Affinitätsmessgerätes mit höchster Empfindlichkeit
- Development of a technology platform for a scalable production of therapeutically relevant stem cells